Original ArticlePreoperative cisplatin, fluorouracil, and docetaxel with or without radiotherapy after poor early response to cisplatin and fluorouracil for resectable oesophageal adenocarcinoma (AGITG DOCTOR): results from a multicentre, randomised controlled phase II trial
Under an Elsevier user license
open archive
Key words
chemotherapy
gastro-oesophageal junction adenocarcinoma
metabolic response
neoadjuvant therapy
oesophageal adenocarcinoma
Cited by (0)
- †
See Acknowledgements for full list of DOCTOR investigators.
Crown Copyright © 2019 Published by Elsevier Ltd on behalf of European Society for Medical Oncology.